Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target is a long noncoding RNA gene transcribed antisense to the protein-coding gene CCR4-NOT transcription complex subunit 7 (CNOT7)[3]. Natural antisense transcripts (NATs) are widespread in eukaryotes and can regulate their sense (coding) partners via mechanisms that include RNA-RNA interactions, transcriptional interference, or effects on chromatin state[5]. Specifically, antisense transcription near the CNOT7 locus could influence CNOT7 gene regulation by modulating chromatin architecture or RNA stability, though the precise function for this particular transcript (ENSG00000289145) is not defined. Such antisense RNAs are not generally considered therapeutic targets, do not encode proteins, and have no established interacting drugs or biomarker utility. Their main significance is in gene regulation, and their roles in disease are generally indirect or still under investigation[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to CCR4-NOT transcription complex subunit 7.